Updated Jul 16, 2026
Disbrow Jarrett is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.

Jarrett Disbrow is the Chief Business Officer at Aytu BioPharma, Inc., a specialty pharmaceutical company focused on prescription therapeutics and consumer health products. He has been involved in the company through various SEC filings, indicating his role in business operations.
| Role | Chief Business Officer |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-10-03 | AYTU | AYTU BIOPHARMA, INC | A — Grant or award | 12.5K | $0.00 | |
| 2025-10-03 | AYTU | AYTU BIOPHARMA, INC | A — Grant or award | 19.6K | $0.00 |
Jarrett Disbrow is the Chief Business Officer at Aytu BioPharma, Inc., a specialty pharmaceutical company focused on prescription therapeutics and consumer health products. He has been involved in the company through various SEC filings, indicating his role in business operations.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Disbrow Jarrett profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.